JP2010524910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524910A5 JP2010524910A5 JP2010503583A JP2010503583A JP2010524910A5 JP 2010524910 A5 JP2010524910 A5 JP 2010524910A5 JP 2010503583 A JP2010503583 A JP 2010503583A JP 2010503583 A JP2010503583 A JP 2010503583A JP 2010524910 A5 JP2010524910 A5 JP 2010524910A5
- Authority
- JP
- Japan
- Prior art keywords
- sfrp3
- therapeutically effective
- derivative
- fragment
- wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000000996 Secreted frizzled-related protein 3 Human genes 0.000 claims 38
- 108010018632 frizzled related protein-3 Proteins 0.000 claims 38
- 239000012634 fragment Substances 0.000 claims 35
- 206010052428 Wound Diseases 0.000 claims 17
- 208000027418 Wounds and injury Diseases 0.000 claims 17
- 206010016654 Fibrosis Diseases 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 6
- 230000004761 fibrosis Effects 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 4
- 230000037390 scarring Effects 0.000 claims 4
- 238000001356 surgical procedure Methods 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 3
- 230000009467 reduction Effects 0.000 claims 3
- 230000001629 suppression Effects 0.000 claims 3
- 208000032544 Cicatrix Diseases 0.000 claims 2
- 108010043958 Peptoids Proteins 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000003176 fibrotic effect Effects 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 231100000241 scar Toxicity 0.000 claims 2
- 230000037387 scars Effects 0.000 claims 2
- 210000001835 viscera Anatomy 0.000 claims 2
- 206010054045 Anterior capsule contraction Diseases 0.000 claims 1
- 208000002177 Cataract Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 150000008574 D-amino acids Chemical class 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 101000864788 Homo sapiens Secreted frizzled-related protein 3 Proteins 0.000 claims 1
- 206010023421 Kidney fibrosis Diseases 0.000 claims 1
- 208000032056 Radiation Fibrosis Syndrome Diseases 0.000 claims 1
- 206010067953 Radiation fibrosis Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 102100030053 Secreted frizzled-related protein 3 Human genes 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 206010067269 Uterine fibrosis Diseases 0.000 claims 1
- 210000000683 abdominal cavity Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 230000001079 digestive effect Effects 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 206010061989 glomerulosclerosis Diseases 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 208000023589 ischemic disease Diseases 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 210000003254 palate Anatomy 0.000 claims 1
- 239000000816 peptidomimetic Substances 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical class O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
- 210000000115 thoracic cavity Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0707348.9A GB0707348D0 (en) | 2007-04-17 | 2007-04-17 | Medicaments and methods for inhibition of scarring |
| PCT/GB2008/001345 WO2008125869A1 (en) | 2007-04-17 | 2008-04-17 | Secreted frizzled related protein 3 for use in the inhibition of scarring |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010524910A JP2010524910A (ja) | 2010-07-22 |
| JP2010524910A5 true JP2010524910A5 (enExample) | 2011-02-03 |
Family
ID=38116837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010503583A Withdrawn JP2010524910A (ja) | 2007-04-17 | 2008-04-17 | 瘢痕の抑制に使用できる分泌性Ｆｒｉｚｚｌｅｄ関連タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100261659A1 (enExample) |
| EP (1) | EP2148726A1 (enExample) |
| JP (1) | JP2010524910A (enExample) |
| AU (1) | AU2008237751A1 (enExample) |
| CA (1) | CA2684368A1 (enExample) |
| GB (1) | GB0707348D0 (enExample) |
| WO (1) | WO2008125869A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8725477B2 (en) | 2008-04-10 | 2014-05-13 | Schlumberger Technology Corporation | Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics |
| WO2009126888A2 (en) | 2008-04-10 | 2009-10-15 | Services Petroliers Schlumberger | Method for characterizing a geological formation traversed by a borehole |
| US8311788B2 (en) | 2009-07-01 | 2012-11-13 | Schlumberger Technology Corporation | Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry |
| KR102022116B1 (ko) | 2011-06-24 | 2019-09-18 | 노노 인코포레이티드 | 허혈에 대한 psd-95 억제제와의 조합 요법 |
| US9241970B2 (en) * | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7049291B2 (en) * | 1996-10-11 | 2006-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and method of using tissue growth-inducing Frzb protein |
| EP1012262A4 (en) * | 1997-08-12 | 2002-11-06 | Human Genome Sciences Inc | HFLP PROTEIN HFLP |
| EP1639097B1 (en) * | 2003-06-25 | 2013-08-07 | Ottawa Health Research Institute | Methods and compositions for modulating stem cell growth and differentiation |
| WO2005070448A2 (en) * | 2004-01-21 | 2005-08-04 | Five Prime Therapeutics, Inc. | Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease |
| US7638128B2 (en) * | 2005-08-19 | 2009-12-29 | The Brigham And Women's Hospital, Inc. | Method of enhancing cardiac tissue repair by administering a SFRP polypeptide |
-
2007
- 2007-04-17 GB GBGB0707348.9A patent/GB0707348D0/en not_active Ceased
-
2008
- 2008-04-17 JP JP2010503583A patent/JP2010524910A/ja not_active Withdrawn
- 2008-04-17 US US12/596,332 patent/US20100261659A1/en not_active Abandoned
- 2008-04-17 AU AU2008237751A patent/AU2008237751A1/en not_active Abandoned
- 2008-04-17 WO PCT/GB2008/001345 patent/WO2008125869A1/en not_active Ceased
- 2008-04-17 CA CA002684368A patent/CA2684368A1/en not_active Abandoned
- 2008-04-17 EP EP08737006A patent/EP2148726A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI875712B (zh) | 孟魯司特與肽的新共軛物 | |
| JP5739908B2 (ja) | 血管形成関連の眼疾患の処置のための組成物および方法 | |
| JP2012211185A (ja) | 創傷治癒のためのｉｌ−１０関連ペプチド | |
| US20080286211A1 (en) | Using mucin glycoproteins in combination with therapeutic agents to treat epithelial lesions and disorders of impaired mucin function | |
| CN105377285B (zh) | 通过血管紧缩素肽的加速的眼睛损伤的治愈 | |
| BR112012001491A2 (pt) | composição de preparação externa para pele | |
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2010524910A5 (enExample) | ||
| RU2012136530A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP6813916B2 (ja) | 薬学的組成物 | |
| JP6158713B2 (ja) | ヒトラクトフェリン由来ペプチド及びその使用 | |
| JP2009535329A5 (enExample) | ||
| JP2013518090A5 (enExample) | ||
| JP2025102868A (ja) | 炎症性サイトカインを阻害するための医薬組成物 | |
| JP2020524689A5 (enExample) | ||
| US20240226238A1 (en) | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction | |
| KR20220079860A (ko) | 신규 펩티드 | |
| JP2016520592A (ja) | マルファン症候群および関連障害の処置におけるアンジオテンシンペプチド | |
| RU2744878C2 (ru) | Ингибиторы дипептидилпептидазы-4 для местного офтальмологического лечения нейродегенеративных заболеваний сетчатки | |
| JP2023503380A (ja) | ペプチド及び炎症の治療におけるそれらの使用 | |
| WO2022058947A1 (en) | Method of reducing intraocular pressure | |
| US20220105082A1 (en) | New formulations containing leukotriene receptor antagonists | |
| ES2891544T3 (es) | Péptidos NTP para su uso en la prevención o reducción de la incidencia de la retención urinaria aguda | |
| EP3167881A1 (en) | Locally administered ethamsylate as a medicament | |
| WO2021108482A1 (en) | Pentapeptide and methods of use thereof |